Evora Biosciences SAS

Manufacturing · France · 1-10 Employees

View Company Info for Free

Overview

Headquarters

Paris, Ile-de-France, France

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About Evora Biosciences SAS

Evora Biosciences specializes in the development of novel immunomodulatory lipopeptides, specifically EVO lipopeptides, which are designed to provide anti-inflammatory effects for autoimmune and inflammatory diseases. Their products are intended for use in dermatology, ophthalmology, and respiratory care, either as standalone therapies or as part of steroid-sparing approaches. The lipopeptides are characterized by their strong anti-inflammatory potency, stability, non-toxicity, and versatility in formulation. The company aims to deliver differentiated therapeutic outcomes for patients in need of innovative treatment options.Explore more
Evora Biosciences SAS's Social MediaPopular SearchesEvora Biosciences SASSIC Code 28,283NAICS Code 32,325Show more

Is Evora Biosciences SAS your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Evora Biosciences SAS is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Evora Biosciences SAS is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Evora Biosciences SAS.

Evora Biosciences SAS Tech Stack

A closer look at the technologies used by Evora Biosciences SAS

Top Manufacturing Companies

Frequently Asked Questions Regarding Evora Biosciences SAS

What is Evora Biosciences SAS's official website?
Evora Biosciences SAS's official website is www.evorabio.com
What is Evora Biosciences SAS's Revenue?
Evora Biosciences SAS's revenue is <$5 Million
What is Evora Biosciences SAS's SIC code?
Evora Biosciences SAS's SIC: 28,283
What is Evora Biosciences SAS's NAICS code?
Evora Biosciences SAS's NAICS: 32,325
How many employees does Evora Biosciences SAS have?
Evora Biosciences SAS has 1-10 employees
What industry does Evora Biosciences SAS belong to?
Evora Biosciences SAS is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What technology does Evora Biosciences SAS use?
Some of the popular technologies that Evora Biosciences SAS uses are: WooCommerce, WordPress.org, PHP, Microsoft 365
What does Evora Biosciences SAS do?

Evora Biosciences specializes in the development of novel immunomodulatory lipopeptides, specifically EVO lipopeptides, which are designed to provide anti-inflammatory effects for autoimmune and inflammatory diseases. Their products are intended for use in dermatology, ophthalmology, and respiratory care, either as standalone therapies or as part o... f steroid-sparing approaches. The lipopeptides are characterized by their strong anti-inflammatory potency, stability, non-toxicity, and versatility in formulation. The company aims to deliver differentiated therapeutic outcomes for patients in need of innovative treatment options.Read More

What are Evora Biosciences SAS social media links?
Evora Biosciences SAS Linkedin page
Is Evora Biosciences SAS a public company?
Evora Biosciences SAS is private company therefore does not currently have an official ticker symbol
See more information about Evora Biosciences SAS

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.